Dec 28, 2017   SOURCE: PR NewsWire

Gastrointestinal (GI) Stents Market - Expected to Reach $472.5 Million by 2025

DUBLIN, Dec. 28, 2017 /PRNewswire/ --

The "Gastrointestinal (GI) Stents Market Analysis by Product (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), by Application (Biliary Disease, Colorectal Cancer, Stomach Cancer) and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global gastrointestinal stents (GI stents) market is expected to reach USD 472.5 million by 2025. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe.

Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents.

Further Key Findings From The Study Suggest:

    --  The market study suggests that biliary stent dominated the overall
        sector in 2016. Incidences of biliary diseases such as bile duct cancer,
        gallstone disease and primary biliary cholangitis are on the rise
        globally, which would drive the growth of biliary stents sector
        positively.

    --  Esophageal stent segment is expected to witness highest growth rate,
        owing to development of self-expanding plastic stents and self-expanding
        metal stents, which have proved to be safe and cost-effective for
        esophageal pathologies.

    --  Approximately, 50% to 75% of patients who are primarily treated with
        endoscopic balloon dilation experience recurrence of the structure
        within 1 year. Such patients are treated with self-expanding metal
        stents, thereby driving the growth of the market segment.

    --  North America occupied the largest revenue share in 2016, due to the
        high rate of diagnosing new cases of gastrointestinal diseases and
        constantly rising awareness regarding commercial availability of
        effective treatments.

    --  In addition, increasing incidences of irritable bowel syndrome,
        colorectal cancer and pancreatic cancer are a few high impact-rendering
        drivers for the market

    --  Asia Pacific is expected to witness a significant growth during the
        forecast period. The presence of countries such as Japan, China and
        India with constantly increasing patient population is a key factor
        anticipated to fuel the market growth in the region.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Gastrointestinal stents Market Variables, Trends & Scope

Chapter 4 Gastrointestinal stents Market: Product Estimates & Trend Analysis

Chapter 5 Gastrointestinal stents Market: Application Estimates & Trend Analysis

Chapter 6 Gastrointestinal stents Market: Regional Estimates & Trend Analysis, by Product & Application

Chapter 7 Competitive Landscape

    --  Boston Scientific
    --  Cook Medical
    --  ELLA-CS, s.r.o.
    --  ConMed
    --  Gore Medical
    --  Taewoong Medical
    --  Hobbs Medical, Inc.
    --  C.R. Bard
    --  Merit Endotek
    --  Olympus America

For more information about this report visit https://www.researchandmarkets.com/research/zb5fqn/gastrointestinal

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/gastrointestinal-gi-stents-market---expected-to-reach-4725-million-by-2025-300575758.html

SOURCE Research and Markets